| Financial Year |
March 31 2023 |
| Monetary Funds |
417,945,530.03 |
| Held-for-trading Financial Assets |
100,050,805.56 |
| Notes Receivable |
353,120,113.95 |
| Accounts Receivable |
636,990,959.32 |
| Advances to Suppliers |
26,074,936.47 |
| Other Receivables |
55,624,044.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
222,100,071.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,099,048.77 |
| Total Current Assets |
1,940,311,492.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,301,474.90 |
| Investment Properties |
32,972,894.79 |
| Fixed Assetes |
494,702,238.56 |
| Under-construction Projects |
272,836,136.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,162,967.09 |
| R&D expenses |
-- |
| Goodwill |
8,830,268.29 |
| Long-Term Deferred and Prepaid Expenses |
33,712,081.49 |
| Deferred Income Tax Assets |
24,454,559.71 |
| Other Non-Current Assets |
28,792,549.89 |
| Sub-Total of Non-Current Assets |
1,082,309,130.64 |
| Total Assets |
3,022,620,623.48 |
| Short-Term Loans |
514,870,521.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
197,112,377.46 |
| Accounts Payable |
430,177,380.39 |
| Accounts Received In Advance |
1,718,321.49 |
| Employee Compensation Payable |
33,060,312.44 |
| Taxes Payable |
23,912,396.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,700,347.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,970,693.82 |
| Other Current Liabilities |
145,534,619.67 |
| Sub-Total of Current Liabilities |
1,473,967,430.70 |
| Long-term Loans |
2,183,695.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,731,500.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,981,921.85 |
| Total Liabilities |
1,555,949,352.55 |
| Paid-In Capital(Or Share Stock) |
85,490,000.00 |
| Capital Surplus |
763,587,183.24 |
| Surplus Reserve |
42,745,000.00 |
| LESS:Treasury Stock |
36,777,300.00 |
| Undistributed Profits |
523,577,996.79 |
| Minority Stockholder's Interest |
91,915,169.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,374,756,101.56 |
| Owner's Equity（Stockholder's Equity） |
1,466,671,270.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,022,620,623.48 |
